{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Genentech", "item": "https://www.patentleaderboard.com/company/genentech"}, {"@type": "ListItem", "position": 3, "name": "Bonnee Rubinfeld", "item": "https://www.patentleaderboard.com/inventor/fl:bo_ln:rubinfeld-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BR

Bonnee Rubinfeld — 19 Patents

Genentech: 12 patents #231 of 2,392Top 10%
CHChiron: 3 patents #187 of 583Top 35%
LSLawrence Livermore National Security: 3 patents #405 of 1,665Top 25%
OPOnyx Pharmaceuticals: 1 patents #25 of 77Top 35%
South San Francisco, CA: #107 of 1,066 inventorsTop 15%
California: #31,067 of 386,348 inventorsTop 9%
Overall (All Time): #229,345 of 4,157,543Top 6%
19 Patents All Time
Bonnee Rubinfeld has been granted 19 US patents while listed as an inventor at Genentech. The first was granted in 1998 and the most recent in October 2024. Bonnee Rubinfeld ranks #229,345 of 4,157,543 US inventors in our database (top 5.5%). Patent records list Bonnee Rubinfeld in South San Francisco, CA, US.

Patents per Year

Patents granted per year, 1998 to 2024Bar chart with a peak of 4 patents in 2014.peak 41998: 3 patents19981999: 1 patents2011: 1 patents20112013: 2 patents2014: 4 patents20142015: 1 patents2017: 3 patents20172018: 1 patents2021: 1 patents20212022: 1 patents2024: 1 patents2024

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12110314 PepCon proteomics standards and methods of use Mathew Gerald Lyman, Deon S. Anex 2024-10-08 $217,747,000
11492380 PepCon proteomics standards and methods of use Mathew Gerald Lyman, Deon S. Anex 2022-11-08 $75,008,000
11066359 Biodegradable surfactants and related compositions, methods and systems Mathew Gerald Lyman, Lawrence C. Dugan, Roald N. Leif, Brian E. Souza, Carlos Valdez 2021-07-20
9994643 Compositions and methods for the diagnosis and treatment of tumor Mark S. Dennis, Paul Polakis 2018-06-12
9632091 Compositions and methods for prostate cancer analysis Siminder Atwal, Jo-Anne Hongo, Mark Lackner, Elizabeth Punnoose, Rajesh Vij 2017-04-25
9593167 Antibodies and immunoconjugates and uses therefor Mark S. Dennis, Paul Polakis, Aya Jakobovits 2017-03-14
9556267 Anti-LRP6 antibodies Eric Bourhis, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida +6 more 2017-01-31
9029511 Compositions and methods for the diagnosis and treatment of tumor Mark S. Dennis, Paul Polakis 2015-05-12
8889847 Antibodies and immunoconjugates and uses therefor Mark S. Dennis, Paul Polakis, Aya Jakobovits 2014-11-18
8871911 Compositions and methods for the diagnosis and treatment of tumor Mark S. Dennis, Paul Polakis 2014-10-28
8846041 Anti-LRP6 antibodies Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa +7 more 2014-09-30
8771966 Immuno-PET imaging of antibodies and immunoconjugates and uses therefor Mark S. Dennis, Jan Marik, Paul Polakis, Simon Williams 2014-07-08
8535675 Compositions and methods for the diagnosis and treatment of tumor Mark S. Dennis, Paul Polakis 2013-09-17
8436147 Antibodies and immunoconjugates and uses therefor Mark S. Dennis, Paul Polakis, Aya Jakobovits 2013-05-07
7947277 Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders James Ernst, Paul Polakis, Venita DeAlmeida 2011-05-24
5948643 Modulators of BRCA1 activity Paul Polakis, Carol Lingenfelter, Terilyn T. Vuong 1999-09-07 $2,584,000
5830684 Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer Robert F. Halenbeck, Kirston E. Koths, Francis P. McCormick, Edward C. O'Rourke, Robin Clark +2 more 1998-11-03 $10,053,000
5763573 GTPase activating protein fragments Francis P. McCormick, Gail L. Wong, Paul Polakis 1998-06-09 $8,093,000
5760203 Gap gene sequences Gail L. Wong, George A. Martin, Francis P. McCormick, Edward C. O'Rourke, Robin Clark 1998-06-02 $7,600,000